Preparing Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist [18F]Ubrogepant to Enable Biodistribution Studies in Non-Human Primate
Kuo‐Hsien Fan, Sjoerd J. Finnema(Itron (United States)), Martin J. Voorbach(AbbVie (United States)), Marc B. Skaddan(AbbVie (United States)), Robert A. Comley(AbbVie (United States))
Cited by 0
Related Papers
Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging
|Annals of Neurology|2020|186
Validation of Diacyl Glycerolacyltransferase I as a Novel Target for the Treatment of Obesity and Dyslipidemia Using a Potent and Selective Small Molecule Inhibitor
|Journal of Medicinal Chemistry|2008|140
A quantitation method for mass spectrometry imaging
|Rapid Communications in Mass Spectrometry|2011|92
Kinetic Modeling of the Tau PET Tracer <sup>18</sup>F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects
|Journal of Nuclear Medicine|2016|77